IONS

MKT CAP:$12B

Ionis Pharmaceuticals Inc

Market Cap

$12B

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$74.48-$5.19 (-6.51%)

Jun 5, 2026

52W High $86.5052W Low $35.24

Company Details

Ionis Pharmaceuticals, Inc., a commercial-stage biotechnology company, provides RNA-targeted medicines in the United States. The company offers TRYNGOLZA reduces triglyceride levels in adults with familial chylomicronemia syndrome (FCS) and...

CEO

—

IPO Date

May 17, 1991

Website

www.ionis.com

Key Metrics TTM

Revenue

$1.1B

+47.5% YoY

Net Income

-$327M

EPS (Diluted)

Free Cash Flow

-$971M

Revenue / Share

$6.42

Gross Margin

98.3%

Operating Margin

-33.3%

Net Margin

-30.9%

FCF Margin

-91.8%

P/S

11.8x

P/E

Earnings Reports

Q2 2026

Aug 5, 2026

PENDING

Q1 2026

Apr 29, 2026

$246M+87.0%

FY 2025

Feb 26, 2026

$944M+33.9%

Q4 2025

Feb 26, 2026

$203M-10.4%

Q3 2025

Oct 29, 2025

$157M+17.1%

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee